Literature DB >> 18456680

Osmotic polyuria: an overlooked mechanism in diabetic nephropathy.

Shinong Wang, Grace M Mitu, Raimund Hirschberg.   

Abstract

Tubulo-interstitial pathology in diabetic nephropathy is thought to be caused by cell injury that is induced by high ambient glucose levels and increased proportions of glycated proteins. Other mechanistic hypotheses engage glomerular ultrafiltration of proteins and bioactive growth factors and their effects on tubular cells. Some scholars promote tubular ischaemia due to reduced peritubular blood flow as a response to glomerular injury. All of these mechanisms contribute to renal tubulo-interstitial injury in diabetic nephropathy. However, they do not well explain observations that have been made in studies of experimental animals and evaluations of human biopsies showing dilated collecting ducts in early diabetic nephropathy. Dilatation of distal nephron segments is routinely seen in human biopsies or in histological sections from experimental diabetic nephropathy and is reminiscent of similar findings in obstructive nephropathy. Moreover, it is these dilated tubules that are the primary source for pro-inflammatory and pro-fibrogenic cytokines and regulators. Based on this large body of observations from this laboratory and the published literature this narrative develops a novel hypothesis where hyperglycaemic, osmotic polyuria play important contributory roles in the initiation and progression of tubulo-interstitial injury in diabetic nephropathy.

Entities:  

Mesh:

Year:  2008        PMID: 18456680     DOI: 10.1093/ndt/gfn115

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

Review 1.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.

Authors:  Po-Ming Chow; Shih-Ping Liu; Yao-Chi Chuang; Kyu-Sung Lee; Tag Keun Yoo; Limin Liao; Jian-Ye Wang; Ming Liu; Budiwan Sumarsono; Jar Jar Jong
Journal:  World J Urol       Date:  2018-05-23       Impact factor: 4.226

Review 3.  Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.

Authors:  Wen-Feng Gao; Ying-Bo Guo; Yu Bai; Xin-Yu Ding; Yong-Ji Yan; Zhen-Qi Wu
Journal:  Int Urol Nephrol       Date:  2016-06-06       Impact factor: 2.370

4.  Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2.

Authors:  Long Zhang; Lihe Chen; Chao Gao; Enuo Chen; Andrea R Lightle; Llewellyn Foulke; Bihong Zhao; Paul J Higgins; Wenzheng Zhang
Journal:  J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 10.121

5.  The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS).

Authors:  Benjamin Gonzalez-Sanchez; Jesus Cendejas-Gomez; J Alejandro Rivera-Ramirez; Jaime O Herrera-Caceres; Daniel Olvera-Posada; Christian I Villeda-Sandoval; Ricardo A Castillejos-Molina; Guillermo Feria-Bernal; Arturo Garcia-Mora; Francisco Rodriguez-Covarrubias
Journal:  World J Urol       Date:  2015-10-14       Impact factor: 4.226

6.  PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.

Authors:  Ramzi Hassouneh; Rania Nasrallah; Joe Zimpelmann; Alex Gutsol; David Eckert; Jamie Ghossein; Kevin D Burns; Richard L Hébert
Journal:  Diabetologia       Date:  2016-03-19       Impact factor: 10.122

7.  Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy.

Authors:  Miguel A Lanaspa; Takuji Ishimoto; Christina Cicerchi; Yoshifuru Tamura; Carlos A Roncal-Jimenez; Wei Chen; Katsuyuki Tanabe; Ana Andres-Hernando; David J Orlicky; Esteban Finol; Shinichiro Inaba; Nanxing Li; Christopher J Rivard; Tomoki Kosugi; Laura G Sanchez-Lozada; J Mark Petrash; Yuri Y Sautin; A Ahsan Ejaz; Wataru Kitagawa; Gabriela E Garcia; David T Bonthron; Aruna Asipu; Christine P Diggle; Bernardo Rodriguez-Iturbe; Takahiko Nakagawa; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

8.  Aqp5 is a new transcriptional target of Dot1a and a regulator of Aqp2.

Authors:  Hongyu Wu; Lihe Chen; Xi Zhang; Qiaoling Zhou; Ju-Mei Li; Stefan Berger; Zea Borok; Beiyun Zhou; Zhou Xiao; Hongling Yin; Mingyao Liu; Ying Wang; Jianping Jin; Michael R Blackburn; Yang Xia; Wenzheng Zhang
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

9.  Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.

Authors:  Chiung-Huei Peng; Hsing-Chun Lin; Chih-Li Lin; Chau-Jong Wang; Chien-Ning Huang
Journal:  J Food Drug Anal       Date:  2018-08-14       Impact factor: 6.157

10.  Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.

Authors:  Monika A Niewczas; Tammy L Sirich; Anna V Mathew; Jan Skupien; Robert P Mohney; James H Warram; Adam Smiles; Xiaoping Huang; Walker Walker; Jaeman Byun; Edward D Karoly; Elizabeth M Kensicki; Gerard T Berry; Joseph V Bonventre; Subramaniam Pennathur; Timothy W Meyer; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2014-01-15       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.